Ici Rechallenge | List of Frontiers open access articles

Case Report

Published on 06 Oct 2022

Case report: A successful re-challenge report of GLS-010 (Zimberelimab), a novel fully humanized mAb to PD-1, in a case of recurrent endometrial cancer

in Cancer Immunity and Immunotherapy

Yeshan Chen
Ai Huang
Qin Yang
Jing Yu
Guiling Li

Frontiers in Immunology

doi 10.3389/fimmu.2022.987345

3,723 views
11 citations

Original Research

Published on 28 Nov 2023

Immune checkpoint inhibitor-induced colitis with endoscopic evaluation in Chinese cancer patients: a single-centre retrospective study

in Cancer Immunity and Immunotherapy

Furong Kou
Jian Li
Yanshuo Cao
Zhi Peng
Ting Xu
Lin Shen
Jifang Gong
Xicheng Wang

Frontiers in Oncology

doi 10.3389/fonc.2023.1285478

2,871 views
5 citations

Systematic Review

Published on 24 Feb 2026

Evolving epidemiology and improving safety of rechallenge in immune checkpoint inhibitor-associated acute kidney injury: an updated meta-analysis

in Cancer Immunity and Immunotherapy

Danyang Zhang
Xia Gu
Danyang Li
Yue Yang
Wenge Li

Frontiers in Immunology

doi 10.3389/fimmu.2026.1777744

192 views

Review

Published on 19 Oct 2022

Immune checkpoint inhibitor related nephrotoxicity: Advances in clinicopathologic features, noninvasive approaches, and therapeutic strategy and rechallenge

in Onconephrology

Jing Miao
Meghan E. Sise
Sandra M. Herrmann

Frontiers in Nephrology

doi 10.3389/fneph.2022.1017921

9,695 views
20 citations

Case Report

Published on 27 Aug 2025

Case Report: Recurrent supraglottitis in a patient with metastatic melanoma treated with ipilimumab and nivolumab

in Skin Cancer

Marisa Palmeri
Sarah A. Weiss
Phillip Purnell

Frontiers in Oncology

doi 10.3389/fonc.2025.1615835

1,956 views
2 citations

Review

Published on 12 Jan 2024

Clinical characteristics and novel strategies of immune checkpoint inhibitor rechallenge therapy for non-small cell lung cancer: a comprehensive review

in Cancer Immunity and Immunotherapy

Hao Zhang
Yujun Hu
Tingting Wu
Yeshan Chen
Bin Yang
Tao Xie

Frontiers in Immunology

doi 10.3389/fimmu.2023.1309055

7,054 views
10 citations

Case Report

Published on 19 Mar 2025

Case Report: Successful immune checkpoint inhibitor rechallenge after sintilimab-induced Guillain-Barré syndrome

in Cancer Immunity and Immunotherapy

Lin Ye
Wan Rong Yue
Hao Shi
Jian Ren Li
Yu Ya Qun

Frontiers in Immunology

doi 10.3389/fimmu.2025.1546886

3,909 views
6 citations

Brief Research Report

Published on 08 Jul 2024

Safety of immune checkpoint inhibitor rechallenge after severe immune-related adverse events: a retrospective analysis

in Skin Cancer

Céline Eldani
Marie Kostine
Maxime Faure
Estibaliz Lazaro
Claire Rigothier
Jean Baptiste Hiriart
Bérénice Teulières
Florian Poullenot
Magalie Haissaguerre
Maeva Zysman

Frontiers in Oncology

doi 10.3389/fonc.2024.1403658

4,563 views
10 citations

Case Report

Published on 12 Jun 2025

Long-term immune checkpoint inhibitor therapy in a patient with metastatic nasopharyngeal carcinoma: a case report

in Cancer Immunity and Immunotherapy

Defeng Qing
Zhiping Lu
Heming Lu

Frontiers in Immunology

doi 10.3389/fimmu.2025.1585844

3,567 views

Systematic Review

Accepted on 16 Feb 2026

Advancing Immune Checkpoint Inhibitor Rechallenge: Key Insights into Efficacy, Safety, and Personalized Strategies in Advanced Solid Tumors

in Cancer Immunity and Immunotherapy

ShiFen Lu
Zhong XIE

Frontiers in Oncology

Articles

Case report: A successful re-challenge report of GLS-010 (Zimberelimab), a novel fully humanized mAb to PD-1, in a case of recurrent endometrial cancer

Immune checkpoint inhibitor-induced colitis with endoscopic evaluation in Chinese cancer patients: a single-centre retrospective study

Evolving epidemiology and improving safety of rechallenge in immune checkpoint inhibitor-associated acute kidney injury: an updated meta-analysis

Immune checkpoint inhibitor related nephrotoxicity: Advances in clinicopathologic features, noninvasive approaches, and therapeutic strategy and rechallenge

Case Report: Recurrent supraglottitis in a patient with metastatic melanoma treated with ipilimumab and nivolumab

Clinical characteristics and novel strategies of immune checkpoint inhibitor rechallenge therapy for non-small cell lung cancer: a comprehensive review

Case Report: Successful immune checkpoint inhibitor rechallenge after sintilimab-induced Guillain-Barré syndrome

Safety of immune checkpoint inhibitor rechallenge after severe immune-related adverse events: a retrospective analysis

Long-term immune checkpoint inhibitor therapy in a patient with metastatic nasopharyngeal carcinoma: a case report

Advancing Immune Checkpoint Inhibitor Rechallenge: Key Insights into Efficacy, Safety, and Personalized Strategies in Advanced Solid Tumors